A detailed history of Btc Capital Management, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Btc Capital Management, Inc. holds 3,435 shares of LGND stock, worth $389,460. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,435
Previous 4,269 19.54%
Holding current value
$389,460
Previous $359,000 4.18%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$82.7 - $110.11 $68,971 - $91,831
-834 Reduced 19.54%
3,435 $344,000
Q2 2024

Jul 19, 2024

SELL
$68.53 - $87.91 $23,026 - $29,537
-336 Reduced 7.3%
4,269 $359,000
Q1 2024

Apr 10, 2024

BUY
$68.64 - $89.2 $15,032 - $19,534
219 Added 4.99%
4,605 $336,000
Q3 2023

Oct 17, 2023

BUY
$58.86 - $72.67 $38,729 - $47,816
658 Added 17.65%
4,386 $262,000
Q2 2023

Jul 11, 2023

BUY
$69.53 - $79.33 $3,267 - $3,728
47 Added 1.28%
3,728 $268,000
Q1 2023

Apr 06, 2023

BUY
$65.67 - $77.08 $241,731 - $283,731
3,681 New
3,681 $270,000
Q3 2022

Oct 17, 2022

BUY
$0.01 - $107.56 $4 - $46,358
431 Added 19.08%
2,690 $232,000
Q2 2022

Jul 25, 2022

SELL
$74.52 - $117.06 $22,057 - $34,649
-296 Reduced 11.59%
2,259 $202,000
Q1 2022

May 06, 2022

SELL
$94.99 - $151.56 $7,979 - $12,731
-84 Reduced 3.18%
2,555 $288,000
Q4 2021

Feb 09, 2022

BUY
$127.69 - $165.85 $336,973 - $437,678
2,639 New
2,639 $408,000
Q2 2021

Aug 02, 2021

SELL
$113.03 - $155.64 $172,370 - $237,350
-1,525 Closed
0 $0
Q1 2021

May 04, 2021

SELL
$99.52 - $215.83 $60,408 - $131,008
-607 Reduced 28.47%
1,525 $233,000
Q4 2020

Jan 28, 2021

BUY
$80.55 - $106.05 $171,732 - $226,098
2,132 New
2,132 $212,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Btc Capital Management, Inc. Portfolio

Follow Btc Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btc Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Btc Capital Management, Inc. with notifications on news.